Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. EyePoint Pharmaceuticals, Inc.
FDA Inspection
•EyePoint Pharmaceuticals, Inc.•April 4, 2018

EyePoint Pharmaceuticals, Inc. – FDA Inspection, Apr 4, 2018

Record Details

This FDA Inspection record concerns EyePoint Pharmaceuticals, Inc., with an inspection on April 4, 2018, issued by the New England District Office, covering human drugs.

Company
EyePoint Pharmaceuticals, Inc.
Inspection Date
April 4, 2018
Product Type
Human Drugs
Office
New England District Office
People
  • Edmund F. Mrak (FDA Associated Person)
  • Steve Y. Rhieu (Company Rep)
  • Yong Wang (Issuing Officer)
View Company Profile

ID · 0db9fefd-9ce7-4f02-8336-60414449746e

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1046783
FDA center
Human Drugs
Project area
New Drug Evaluation
Outcome
Form 483 issued

FDA Citations

6
  1. 21 CFR 211.110(a)Control procedures fail to include the following
  2. 21 CFR 211.113(b)Procedures for sterile drug products
  3. 21 CFR 211.160(b)Scientifically sound laboratory controls
  4. 21 CFR 211.165(a)Testing and release for distribution
  5. 21 CFR 211.167(a)Sterility/pyrogen-free testing
  6. 21 CFR 211.94(d)Written Procedures to Remove Pyrogens

Full citation text and observation details available on the Dashboard.

Other FDA inspections of EyePoint Pharmaceuticals, Inc.

4
DateClassificationOfficeProject area
February 15, 2024Not classifiedNew England District OfficeDrug Quality Assurance
September 1, 2021VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 28, 2019OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 19, 2018Not classifiedNew England District Office
Other documents for EyePoint Pharmaceuticals, Inc.
  • FDA Inspection 1230113 - 2024-02-15
  • FDA Inspection 1150669 - 2021-09-01
  • FDA Inspection 1102130 - 2019-08-28
  • FDA Inspection 1067552 - 2018-09-19

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore EyePoint Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.